Yuseon Cheong

Yuseon Cheong

Auto-generated profile, based on publicly available information

Yuseon Cheong

Department of Anesthesiology and Pain Medicine, Kangwon National University Hospital, Chuncheon, Korea

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2016 in The Korean Journal of Pain
Verified
Journal Article
Open access
HKHyun Jung Kim
Hyun Jung Kim
HAHyeong Sik Ahn
Hyeong Sik Ahn
JLJae Young Lee
Jae Young Lee
SCSeong-Soo Choi
Seong-Soo Choi
YCYu Seon Cheong
Yu Seon Cheong
JLJeong Gill Leem
Jeong Gill Leem
Postherpetic neuralgia (PHN) is a common and painful complication of acute herpes zoster. In some cases, it is refractory to medical treatment. Preventing its occurrence is an important issue. We hypothesized that applying nerve blocks during the acute phase of herpes zoster could reduce PHN incidence by attenuating central sensitization and minimizing nerve damage and the anti-inflammatory effects of local anesthetics and steroids. This systematic review and meta-analysis evaluates the efficacy of using nerve blocks to prevent PHN. We searched the MEDLINE, EMBASE, Cochrane Library, ClinicalTrials.gov and KoreaMed databases without language restrictions on April, 30 2014. We included all randomized controlled trials performed within 3 weeks after the onset of herpes zoster in order to compare nerve blocks vs active placebo and standard therapy. Nine trials were included in this systematic review and meta-analysis. Nerve blocks reduced the duration of herpes zoster-related pain and PHN incidence of at 3, 6, and 12 months after final intervention. Stellate ganglion block and single epidural injection did not achieve positive outcomes, but administering paravertebral blockage and continuous/repeated epidural blocks reduced PHN incidence at 3 months. None of the included trials reported clinically meaningful serious adverse events. Applying nerve blocks during the acute phase of the herpes zoster shortens the duration of zoster-related pain, and somatic blocks (including paravertebral and repeated/continuous epidural blocks) are recommended to prevent PHN. In future studies, consensus-based PHN definitions, clinical cutoff points that define successful treatment outcomes and standardized outcome-assessment tools will be needed.

1 July 2010 in European Journal of Anaesthesiology
Verified
Journal Article
Closed access
WSWon-Jung Shin
Won-Jung Shin
YCYu-Seon Cheong
Yu-Seon Cheong
HYHong-Seuk Yang
Hong-Seuk Yang
TNTomoki Nishiyama
Tomoki Nishiyama
The I-gel is a new single-use supraglottic airway device without an inflatable cuff. This study was designed to investigate the usefulness of the I-gel compared with the classic laryngeal mask airway (cLMA) and ProSeal laryngeal mask airway (pLMA) in anaesthetized, paralysed patients. The American Society of Anesthesiologists physical status I-II patients (n = 167) scheduled for orthopaedic surgery were included in this prospective study. General anaesthesia was achieved with intravenous infusion of propofol, remifentanil and rocuronium. The patients were randomly assigned to I-gel, pLMA and cLMA groups (64, 53 and 50 patients, respectively). Properly sized I-gel (No. 3-4) or LMA (No. 4-5) was inserted. We assessed haemodynamic data, airway leak pressure, leak volume, success rates and postoperative complications. There were no differences in the demographic data and haemodynamic data immediately after insertion of devices among the three groups. The airway leak pressures of the I-gel group (27.1 +/- 6.4 cmH2O) and pLMA group (29.8 +/- 5.7 cmH2O) were significantly higher than that of the cLMA group (24.7 +/- 6.2 cmH2O). The success rates for first attempt of insertion were similar among the three groups (P = 0.670). There were no differences in the incidence of adverse events except for the larger incidence of sore throat in the cLMA group. I-gel may have a similar airway sealing to that of pLMA, higher than that of cLMA, and is not associated with adverse events. The I-gel might be an effective alternative as a supraglottic airway device.

21 August 2015 in European Spine Journal
Verified
Journal Article
Closed access
PDF file
YKYoung Uk Kim
Young Uk Kim
YKYu-Gyeong Kong
Yu-Gyeong Kong
JLJonghyuk Lee
Jonghyuk Lee
YCYuseon Cheong
Yuseon Cheong
SKSe Hun Kim
Se Hun Kim
JSJeonghun Suh
Jeonghun Suh

31 October 2014 in The Korean Journal of Pain
Verified
Journal Article
Open access
PDF file
JNJae-Sik Nam
Jae-Sik Nam
YCYu Seon Cheong
Yu Seon Cheong
MKMyong-Hwan Karm
Myong-Hwan Karm
HAHo Soo Ahn
Ho Soo Ahn
JSJi Hoon Sim
Ji Hoon Sim
JLJeong Gil Leem
Jeong Gil Leem
Nam JS, et al. Korean J Pain. 2014 Oct;27(4):326-333. http://dx.doi.org/10.3344/kjp.2014.27.4.326

30 September 2016 in Journal of Lifestyle Medicine
Verified
Journal Article
Open access
YCYuseon Cheong
Yuseon Cheong
SKSeong Sik Kang
Seong Sik Kang
MKMinsoo Kim
Minsoo Kim
HSHee Jeong Son
Hee Jeong Son
JPJaewoo Park
Jaewoo Park
JKJeong-Mo Kim
Jeong-Mo Kim
Airway management in patients with complex maxillofacial injuries is a challenge to anesthesiologists. Submental intubation is a useful technique that is less invasive than tracheostomy in securing the airways where orotracheal and nasotracheal intubation cannot be performed. This procedure avoids the use of tracheostomy and bypasses its associated morbidities. A flexible and kink-resistant reinforced endotracheal tube with detachable universal connector is commonly used for submental intubation. Herein, we report cases involving submental intubation using a reinforced endotracheal tube with a non-detachable universal connector in patients with complex maxillofacial injuries.

30 October 2021 in Anesthesia and Pain Medicine
Verified
Journal Article
Open access
PDF file
YCYuseon Cheong
Yuseon Cheong
SLSangho Lee
Sangho Lee
DLDo-Kyeong Lee
Do-Kyeong Lee
KKKyoung-Sun Kim
Kyoung-Sun Kim
BSBo-Hyun Sang
Bo-Hyun Sang
GHGyu-Sam Hwang
Gyu-Sam Hwang
Background: Generally, lactate levels > 2 mmol/L represent hyperlactatemia, whereas lactic acidosis is often defined as lactate > 4 mmol/L. Although hyperlactatemia is common finding in liver transplant (LT) candidates, association between lactate and organ failures with Acute-on-chronic Liver Failure (ACLF) is poorly studied. We searched the important variables for pre-LT hyperlactatemia and examined the impact of preoperative hyperlactatemia on early mortality after LT. Methods: A total of 2,002 patients from LT registry between January 2008 and February 2019 were analyzed. Six organ failures (liver, kidney, brain, coagulation, circulation, and lung) were defined by criteria of EASL-CLIF ACLF Consortium. Variable importance of preoperative hyperlactatemia was examined by machine learning using random survival forest (RSF). Kaplan-Meier Survival curve analysis was performed to assess 90-day mortality.Results: Median lactate level was 1.9 mmol/L (interquartile range: 1.4, 2.4 mmol/L) and 107 (5.3%) patients showed > 4.0 mmol/L. RSF analysis revealed that the four most important variables for hyperlactatemia were MELD score, circulatory failure, hemoglobin, and respiratory failure. The 30-day and 90-day mortality rates were 2.7% and 5.1%, whereas patients with lactate > 4.0 mmol/L showed increased rate of 15.0% and 19.6%, respectively. Conclusion: About 50% and 5% of LT candidates showed pre-LT hyperlactatemia of > 2.0 mmol/L and > 4.0 mmol/L, respectively. Pre-LT lactate > 4.0 mmol/L was associated with increased early post-LT mortality. Our results suggest that future study of correcting modifiable risk factors may play a role in preventing hyperlactatemia and lowering early mortality after LT.